Ayer Capital Management, LP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Ayer Capital Management, LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ayer Capital Management, LP. Ayer Capital Management, LP is a 10% Owner in ABEONA THERAPEUTICS INC. ($AKC) and a 10% Owner in Oncothyreon Inc. ($ONTY) and a 10% Owner in Lion Biotechnologies, Inc. ($LBIO) and a Director in Lion Biotechnologies, Inc. ($LBIO).
Address: 230 CALIFORNIA, SUITE 600 SAN FRANCISCO 94111 CA
Companies in which Ayer Capital Management, LP is an Insider
ABEONA THERAPEUTICS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ayer Capital Management, LP: 10% Owner
Holdings: 2,413,163 shares
Latest Transaction: Jun 29 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Ayer Capital Management, LP: 10% Owner
Holdings: 2,985,238 shares
Latest Transaction: Jun 27 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IOVANCE BIOTHERAPEUTICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ayer Capital Management, LP: 10% Owner, Director
Holdings: 2,823,333 shares
Current Value: $20,045,664
Latest Transaction: May 08 2015
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ayer Capital Management, LP
Sentiment: All, AKC, CASC, IOVA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2015 | LBIO | Lion Biotechnologi ... | Ayer Capital Management, LP | 10% Owner | Sell | S | 9.62 | 2,780,682 | 26,752,385 | 2,823,333 | 5.6 M to 2.8 M (-49.62 %) |
| Jul 23 2014 | LBIO | Lion Biotechnologi ... | Ayer Capital Management, LP | Director | Option Exercise | C | 1.25 | 1 | 1 | 0 | |
| Jul 23 2014 | LBIO | Lion Biotechnologi ... | Ayer Capital Management, LP | Director | Option Exercise | C | 1.25 | 1 | 1 | 0 | |
| Jul 23 2014 | LBIO | Lion Biotechnologi ... | Ayer Capital Management, LP | Director | Option Exercise | C | 1.00 | 1 | 1 | 0 | |
| Jul 23 2014 | LBIO | Lion Biotechnologi ... | Ayer Capital Management, LP | Director | Option Exercise | C | 1.00 | 1 | 1 | 0 | |
| Jul 23 2014 | LBIO | Lion Biotechnologi ... | Ayer Capital Management, LP | Director | Buy | J | 0.05 | 560,088,650 | 27,444,344 | 560,401,150 | 312.5 K to 560.4 M (+179,228.37 %) |
| Jun 29 2012 | AKC | ABEONA THERAPEUTIC ... | Ayer Capital Management, LP | 10% Owner | Sell | S | 0.55 | 179,157 | 99,074 | 2,413,163 | 2.6 M to 2.4 M (-6.91 %) |